The present study investigated whether the TGFβ1 level in CAFs of resected tumors of patients with SCLC may be an indicator of prognosis, and furthermore the effect of this level on the proliferation and radiotherapeutic sensitivity of tumor cells and tumor immune status. Here, TGFB1 is linked to neoplasm.